NCT05179109

Brief Summary

The objective of this study is to examine whether robot-assisted laparoscopy is superior compared to conventional laparoscopy as regards to patient outcome.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Oct 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Oct 2022Dec 2026

First Submitted

Initial submission to the registry

December 7, 2021

Completed
29 days until next milestone

First Posted

Study publicly available on registry

January 5, 2022

Completed
9 months until next milestone

Study Start

First participant enrolled

October 3, 2022

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

December 6, 2024

Status Verified

December 1, 2024

Enrollment Period

3.2 years

First QC Date

December 7, 2021

Last Update Submit

December 3, 2024

Conditions

Keywords

Endometriosis surgeryDeep endometriosis surgeryRobotic surgery

Outcome Measures

Primary Outcomes (1)

  • NRS (Numeric rating scale) Score for pain

    The surgical outcome as regards to pain symptoms (NRS questionnaire), absolute scores and change from baseline for both study groups.

    Immediately postoperatively (24 hours) and 6, 12 and 24 months postoperatively

Secondary Outcomes (7)

  • Intraoperative measures

    Up to 300 minutes (intraoperative)

  • Factors concerning ERAS (Enhanced recovery after surgery)

    Up to 7 days (Hospital stay)

  • Cost

    Primary hospital stay and 24 months, for both study groups.

  • Complications

    30 days

  • Endometriosis-related quality-of-life

    6, 12 and 24 months

  • +2 more secondary outcomes

Study Arms (2)

Robot-assisted laparoscopy

EXPERIMENTAL

Surgery for deep endometriosis using robot-assisted laparoscopy.

Procedure: Minimally invasive surgery

Conventional laparoscopy

ACTIVE COMPARATOR

Surgery for deep endometriosis using conventional laparoscopy.

Procedure: Minimally invasive surgery

Interventions

Minimally invasive surgery for severe deep endometriosis

Conventional laparoscopyRobot-assisted laparoscopy

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ASA (American Society of Anesthesiologists physical status classification) 1-3
  • Diagnosed deep endometriosis (MRI)
  • Patient has symptoms
  • Operative treatment is indicated
  • Patient is able to give informed consent

You may not qualify if:

  • ASA \> 3
  • Recurring rectosigmoid endometriosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northern Ostrobothnia Hospital District

Oulu, 90220, Finland

RECRUITING

Related Publications (1)

  • Terho AM, Makela-Kaikkonen J, Ohtonen P, Uimari O, Puhto T, Rautio T, Koivurova S. Robotic versus laparoscopic surgery for severe deep endometriosis: protocol for a randomised controlled trial (ROBEndo trial). BMJ Open. 2022 Jul 18;12(7):e063572. doi: 10.1136/bmjopen-2022-063572.

MeSH Terms

Conditions

Endometriosis

Interventions

Minimally Invasive Surgical Procedures

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Study Officials

  • Sari Koivurova, MD, PhD

    Oulu University Hospital, Department of Obstetrics and Gynecology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anna M Terho, MD

CONTACT

Sari Koivurova, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a prospective, randomized, controlled clinical trial with an allocation ratio of 1:1.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Chief of Gynecology

Study Record Dates

First Submitted

December 7, 2021

First Posted

January 5, 2022

Study Start

October 3, 2022

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

December 6, 2024

Record last verified: 2024-12

Locations